OClawVPS.com
Abalone Bio
Edit

Abalone Bio

https://www.abalonebio.com/
Last activity: 06.01.2026
Active
Categories: BioTechChemicalDrugFastGrowthLivingMedTechPlatformTechnology
The remarkable specificity and safety of antibody drugs have been limited to blocking inactivators for the largest class of drug targets. Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.
Followers
639
Mentions
5
Location: United States, California, Emeryville
Employees: 11-50
Founded date: 2017

Investors 5

Mentions in press and media 5

DateTitleDescription
06.01.2026Abalone Bio and Pfizer Launch Research Collaboration to Discover GPCR-Modulating AntibodiesThe collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed target EMERYVILLE, CA, UNITED STATES, January 6, 2026 /EINPresswire.com/ -- Abalone Bio, a therapeutics biotech company that ...
30.10.2025Abalone Bio & Sihuan Pharmaceutical Launch Collaboration to Develop a Novel Obesity DrugEMERYVILLE, CA, UNITED STATES, October 30, 2025 /EINPresswire.com/ -- Abalone Bio, the only therapeutics biotech company measuring the large-scale activity datasets needed for AI-powered discovery and design of rare activating antibodies th...
12.08.2025Abalone Bio and Mount Sinai Publish Preclinical Data on World's First CB2 Antibody AgonistsAbalone Bio characterizes in vitro and ex vivo activities of novel antibody agonists produced by their FAST Platform EMERYVILLE, CA, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Abalone Bio, the only antibody drug company measuring ...
25.10.2022Preclinical biotherapeutics company Abalone Bio and bioinformatics cloud platform provider PipeBio announce collaborative efforts in antibody drug discoveryAbalone Bio's and PipeBio's announcement of ongoing collaboration PipeBio’s advanced bioinformatics platform and its integrated workflows support preclinical biotherapeutics company Abalone Bio’s proprietary antibody discovery platform for ...
17.03.2020All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and NonprofitsY Combinator’s Demo Day was a bit different this time around. As concerns grew over the spread of COVID-19, Y Combinator shifted the event format away from the two-day gathering in San Francisco we’ve gotten used to, instead opting to have ...

Reviews 0

Sign up to leave a review

Sign up Log In